PGNX - Progenics Pharmaceuticals Inc.

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

PGNX - Progenics Pharmaceuticals Inc.

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ
#974()/5610

Wed 13'th Dec 2017

PERIOD 2017-09-14 - 2017-12-13
CHANGE 9.87%
PRICE $6.12
VOLUME
Buy
TREND
Sell

MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Buy

Request Prediction
0.00%
Predict

Progenics Pharmaceuticals Inc. Stock Analysis

Technical stock analysis for Wed 13'th Dec 2017

Shorts 7.37% ( 2017-11-15 )
Cash 477.5 mill
Loans 99.2 mill
Beta 3.41
ROA -35.07
Buy candidate since 2017-12-12 Gain 9.87%

Progenics Pharmaceuticals Inc. gained 9.87% in the last trading day, rising from $5.57 to $6.12 The price has been going up and down for this period, and there has been a 8.51% gain for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 1.25 million more shares were traded than the day before. In total, 2.04 million shares bought and sold for approximately $12.46 million.

Access today's Top 5 Buy Candidates

Trend

Progenics Pharmaceuticals Inc. lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $6.16 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -23.99% during the next 3 months and, with 90% probability hold a price between $3.54 and $4.68 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Only positive signals in the chart today. Progenics Pharmaceuticals Inc. holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $5.80 and $5.73. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday December 12, 2017, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 60 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Progenics Pharmaceuticals Inc. finds support from accumulated volume at $6.11. On the upside the stock meets some resistance just above today's level from accumulated volume at $6.37, $6.66 and $7.10.

The stock is about to test the resistance from accumulated volume at $6.37 and this may cause the stock to take a minor break or get into a more sideways move for a few days.

Support: $6.11 Price: $6.12 Resistance: $6.37

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.48 (8.51%) between high and low. For the last week, the stock has had a daily average volatility of 7.13%.

Our recommended stoploss: $5.86 (-4.22%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Buy Candidate.

Buy PGNX CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Access these features

Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder
Ad-free browsing

Become a PRO Now
Help us IMPROVE our CHARTS HERE.

Recommended
books of the week

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

START FREE 5-DAY TRIAL